Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#1840
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+1.79%
Mudança mensal
+11.53%
Mudança em 6 meses
+56.39%
Mudança anual
+56.39%
Fechamento anterior
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Volume
74
Mercados
Ações
Cuidados de saúde
ANAB
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
30.43 M
30.67 M
29.38 M
28 M
27.69 M
—
Valuation ratios
Enterprise value
827.78 M
282.95 M
447.55 M
577.23 M
737.99 M
2.05 B
Price to earnings ratio
-5.51
-2.59
-3.91
-5.06
-11.22
-22.76
Price to sales ratio
16.02
4.12
4.75
5.21
5.28
19.36
Price to cash flow ratio
-8.78
-2.78
-4.83
-5.03
-6.13
-18.76
Price to book ratio
3.96
5.3
2.65
4.31
28.07
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.05
0.09
0.12
0.04
0.3
Return on equity %
0.39
0.31
1.16
0.86
0.51
2.84
Return on invested capital %
167.79
76.13
190.36
197.25
244.78
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
75.81
22.43
99.16
117.55
45.47
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
109.44
50.53
141.62
173.52
19.8
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.23
9.51
8.25
8.22
8.68
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.09
0.06
0.06
0.22
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.35
2.35
0.35
1.4
0.94
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
14.89
13.58
11.09
9.22
8.58
42.47
Net current asset value per share
15.53
15.22
11.85
10.13
11.39
48.59
Tangible book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Working capital per share
14.01
13.62
10.41
8.9
10.08
43.01
Book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Notícias
FDA aceita pedido da Vanda para imsidolimab no tratamento de doença rara de pele
FDA accepts Vanda’s imsidolimab application for rare skin disorder
Ações da AnaptysBio atingem máxima de 52 semanas a US$ 57,73
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
Ação da AnaptysBio atinge máxima de 52 semanas a US$ 52,56
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Ação da AnaptysBio: UBS reitera classificação de Compra em meio a litígio com GSK
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation
Acordo de US$ 500 milhões entre Royalty Pharma e Teva impulsiona ações da AnaptysBio